237 related articles for article (PubMed ID: 26673122)
1. New Insights into the High-Density Lipoprotein Dilemma.
Pownall HJ; Gotto AM
Trends Endocrinol Metab; 2016 Jan; 27(1):44-53. PubMed ID: 26673122
[TBL] [Abstract][Full Text] [Related]
2. Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL.
Hui N; Barter PJ; Ong KL; Rye KA
Clin Sci (Lond); 2019 Nov; 133(21):2221-2235. PubMed ID: 31722013
[TBL] [Abstract][Full Text] [Related]
3. Micro-RNAs and High-Density Lipoprotein Metabolism.
Canfrán-Duque A; Lin CS; Goedeke L; Suárez Y; Fernández-Hernando C
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1076-84. PubMed ID: 27079881
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein A-II is a key regulatory factor of HDL metabolism as appears from studies with transgenic animals and clinical outcomes.
Maïga SF; Kalopissis AD; Chabert M
Biochimie; 2014 Jan; 96():56-66. PubMed ID: 24012775
[TBL] [Abstract][Full Text] [Related]
5. An overview of the new frontiers in the treatment of atherogenic dyslipidemias.
Rached FH; Chapman MJ; Kontush A
Clin Pharmacol Ther; 2014 Jul; 96(1):57-63. PubMed ID: 24727469
[TBL] [Abstract][Full Text] [Related]
6. Effects of curcumin on HDL functionality.
Ganjali S; Blesso CN; Banach M; Pirro M; Majeed M; Sahebkar A
Pharmacol Res; 2017 May; 119():208-218. PubMed ID: 28192240
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans.
Vaisar T; Shao B; Green PS; Oda MN; Oram JF; Heinecke JW
Curr Atheroscler Rep; 2007 Nov; 9(5):417-24. PubMed ID: 18001626
[TBL] [Abstract][Full Text] [Related]
8. HDL cholesterol efflux capacity and incident cardiovascular events.
Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
[TBL] [Abstract][Full Text] [Related]
9. The Alcohol-High-Density Lipoprotein Athero-Protective Axis.
Rosales C; Gillard BK; Gotto AM; Pownall HJ
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630283
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives.
Trius-Soler M; Mukamal KJ; Guasch-Ferré M
Curr Opin Lipidol; 2024 Feb; 35(1):25-32. PubMed ID: 37788374
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases.
Dabravolski SA; Bezsonov EE; Baig MS; Popkova TV; Orekhov AN
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34203309
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease.
Liao D; Yang X; Wang H
Clin Chem Lab Med; 2007; 45(12):1652-9. PubMed ID: 18020970
[TBL] [Abstract][Full Text] [Related]
13. Inflammation alters HDL composition and function: implications for HDL-raising therapies.
Marsche G; Saemann MD; Heinemann A; Holzer M
Pharmacol Ther; 2013 Mar; 137(3):341-51. PubMed ID: 23246719
[TBL] [Abstract][Full Text] [Related]
14. Beginning to understand high-density lipoproteins.
Santos-Gallego CG; Badimon JJ; Rosenson RS
Endocrinol Metab Clin North Am; 2014 Dec; 43(4):913-47. PubMed ID: 25432389
[TBL] [Abstract][Full Text] [Related]
15. High-density lipoproteins: a consensus statement from the National Lipid Association.
Toth PP; Barter PJ; Rosenson RS; Boden WE; Chapman MJ; Cuchel M; D'Agostino RB; Davidson MH; Davidson WS; Heinecke JW; Karas RH; Kontush A; Krauss RM; Miller M; Rader DJ
J Clin Lipidol; 2013; 7(5):484-525. PubMed ID: 24079290
[TBL] [Abstract][Full Text] [Related]
16. Biological Consequences of Dysfunctional HDL.
Pirillo A; Catapano AL; Norata GD
Curr Med Chem; 2019; 26(9):1644-1664. PubMed ID: 29848265
[TBL] [Abstract][Full Text] [Related]
17. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
[TBL] [Abstract][Full Text] [Related]
18. Dietary fatty acids and lipoprotein metabolism: new insights and updates.
Ooi EM; Ng TW; Watts GF; Barrett PH
Curr Opin Lipidol; 2013 Jun; 24(3):192-7. PubMed ID: 23619368
[TBL] [Abstract][Full Text] [Related]
19. HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role.
Casula M; Colpani O; Xie S; Catapano AL; Baragetti A
Cells; 2021 Jul; 10(8):. PubMed ID: 34440638
[TBL] [Abstract][Full Text] [Related]
20. Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels.
Hausenloy DJ; Yellon DM
Curr Opin Cardiol; 2009 Sep; 24(5):473-82. PubMed ID: 19574922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
